Skip to main content
Erschienen in: Clinical Oral Investigations 3/2011

01.06.2011 | Original Article

MAGE-A antigens in lesions of the oral mucosa

verfasst von: Eva Krauss, Stephan Rauthe, Stefan Gattenlöhner, Tobias Reuther, Michael Kochel, Ulrike Kriegebaum, Alexander C. Kübler, Urs D. A. Müller-Richter

Erschienen in: Clinical Oral Investigations | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Oral squamous cell carcinoma develops continuously out of predamaged oral mucosa. For the physician and pathologist, difficulties arise in distinguishing precancerous from cancerous lesions. MAGE-A antigens are tumor antigens that are found solely in malignant transformed cells. These antigens might be useful in distinguishing precancerous from cancerous lesions. The aim of this study was to verify this assumption by comparing MAGE-A expression in benign, precancerous, and cancerous lesions of the oral mucosa. Retrospectively, biopsies of different oral lesions were randomly selected. The lesions that were included are 64 benign oral lesions (25 traumatic lesions (oral ulcers), 13 dental follicles, and 26 epulis), 26 oral lichen planus, 123 epithelial precursor lesions (32 epithelial hyperplasia found in leukoplakias, 24 epithelial dysplasia found in leukoplakias, 26 erythroplasia with oral epithelial dysplasia, and 41 carcinomas in situ in erythroleukoplakias). The lesions were immunohistochemically stained with the poly-MAGE-A antibody 57B, and the results were compared. Biopsies of oral lichen planus, oral ulcers, dental follicles, epulis, and leukoplakia without dysplasia showed no positive staining for MAGE-A antigens. Leukoplakia with dysplasia, dysplasia, and carcinomata in situ displayed positive staining in 33%, 65%, and 56% of the cases, respectively. MAGE-A antigens were not detectable via immunohistochemistry in benign lesions of the oral mucosa. The staining rate of dysplastic precancerous lesions or malignant lesions ranged from 33% to 65%. The MAGE-A antigens might facilitate better differentiation between precancerous and cancerous lesions of the oral mucosa.
Literatur
1.
Zurück zum Zitat Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW (2008) Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 44:1345–1389PubMedCrossRef Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW (2008) Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 44:1345–1389PubMedCrossRef
2.
Zurück zum Zitat Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581–592PubMedCrossRef Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581–592PubMedCrossRef
3.
Zurück zum Zitat Boyle P, Ferlay J (2005) Cancer incidence and mortality in Europe, 2004. Ann Oncol 16:481–488PubMedCrossRef Boyle P, Ferlay J (2005) Cancer incidence and mortality in Europe, 2004. Ann Oncol 16:481–488PubMedCrossRef
4.
Zurück zum Zitat Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C (2003) Mortality from major cancer sites in the European Union, 1955–1998. Ann Oncol 14:490–495PubMedCrossRef Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C (2003) Mortality from major cancer sites in the European Union, 1955–1998. Ann Oncol 14:490–495PubMedCrossRef
5.
Zurück zum Zitat Bagan JV, Scully C (2008) Recent advances in Oral Oncology 2007: epidemiology, aetiopathogenesis, diagnosis and prognostication. Oral Oncol 44:103–108PubMedCrossRef Bagan JV, Scully C (2008) Recent advances in Oral Oncology 2007: epidemiology, aetiopathogenesis, diagnosis and prognostication. Oral Oncol 44:103–108PubMedCrossRef
6.
Zurück zum Zitat Folz BJ, Silver CE, Rinaldo A, Fagan JJ, Pratt LW, Weir N, Seitz D, Ferlito A (2008) An outline of the history of head and neck oncology. Oral Oncol 44:2–9PubMedCrossRef Folz BJ, Silver CE, Rinaldo A, Fagan JJ, Pratt LW, Weir N, Seitz D, Ferlito A (2008) An outline of the history of head and neck oncology. Oral Oncol 44:2–9PubMedCrossRef
7.
Zurück zum Zitat Lung T, Tascau OC, Almasan HA, Muresan O (2007) Head and neck cancer, treatment, evolution and post therapeutic survival—part 2: a decade's results 1993–2002. J Cranio-maxillo-facial Surg 35:126–131CrossRef Lung T, Tascau OC, Almasan HA, Muresan O (2007) Head and neck cancer, treatment, evolution and post therapeutic survival—part 2: a decade's results 1993–2002. J Cranio-maxillo-facial Surg 35:126–131CrossRef
8.
Zurück zum Zitat Gondos A, Arndt V, Holleczek B, Stegmaier C, Ziegler H, Brenner H (2007) Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis. Int J Cancer 121:395–400PubMedCrossRef Gondos A, Arndt V, Holleczek B, Stegmaier C, Ziegler H, Brenner H (2007) Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis. Int J Cancer 121:395–400PubMedCrossRef
9.
Zurück zum Zitat Reichart PA (2007) Orale Leukoplakie/Erythroplakie. Stellungnahme der Deutschen Gesellschaft für Zahn-, Mund- und Kieferheilkunde (DGZMK). Dtsch Zahnarztl Z 62:45–48 Reichart PA (2007) Orale Leukoplakie/Erythroplakie. Stellungnahme der Deutschen Gesellschaft für Zahn-, Mund- und Kieferheilkunde (DGZMK). Dtsch Zahnarztl Z 62:45–48
10.
Zurück zum Zitat Scheifele C, Reichart PA (2003) Is there a natural limit of the transformation rate of oral leukoplakia? Oral Oncol 39:470–475PubMedCrossRef Scheifele C, Reichart PA (2003) Is there a natural limit of the transformation rate of oral leukoplakia? Oral Oncol 39:470–475PubMedCrossRef
11.
Zurück zum Zitat Driemel O, Hertel K, Reichert TE, Kosmehl H (2006) Aktuelle Klassifikation der Präkursorläsionen des oralen Plattenepithelkarzinoms. Prinzipien der WHO-Klassifikation 2005. Mund Kiefer Gesichtschir 10:89–93PubMedCrossRef Driemel O, Hertel K, Reichert TE, Kosmehl H (2006) Aktuelle Klassifikation der Präkursorläsionen des oralen Plattenepithelkarzinoms. Prinzipien der WHO-Klassifikation 2005. Mund Kiefer Gesichtschir 10:89–93PubMedCrossRef
12.
Zurück zum Zitat Gale N, Pilch BZ, Sidransky D, Westra WH, Califano J (2005) Epithelial precursor lesions. IARC, Lyon Gale N, Pilch BZ, Sidransky D, Westra WH, Califano J (2005) Epithelial precursor lesions. IARC, Lyon
13.
Zurück zum Zitat Batzler WU GK, Hentschel S, Husmann G, Kaatsch P, Katalanic A, Kieschke J, Kraywinkel K, Meyer M, Stabenow R, Stegmaier C, Bertz J, Hberland J, Wolf U (2008) Krebs in Deutschland 2003–2004. Häufigkeiten und Trends. Robert Koch-Institut (Hrsg) und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. (Hrsg), Berlin Batzler WU GK, Hentschel S, Husmann G, Kaatsch P, Katalanic A, Kieschke J, Kraywinkel K, Meyer M, Stabenow R, Stegmaier C, Bertz J, Hberland J, Wolf U (2008) Krebs in Deutschland 2003–2004. Häufigkeiten und Trends. Robert Koch-Institut (Hrsg) und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. (Hrsg), Berlin
14.
Zurück zum Zitat Bray I, Brennan P, Boffetta P (2000) Projections of alcohol- and tobacco-related cancer mortality in Central Europe. Int J Cancer 87:122–128PubMedCrossRef Bray I, Brennan P, Boffetta P (2000) Projections of alcohol- and tobacco-related cancer mortality in Central Europe. Int J Cancer 87:122–128PubMedCrossRef
15.
Zurück zum Zitat Rosenquist K (2005) Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Swed Dent J Suppl 179:1–66PubMed Rosenquist K (2005) Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Swed Dent J Suppl 179:1–66PubMed
16.
Zurück zum Zitat Rosenquist K, Wennerberg J, Annertz K, Schildt EB, Hansson BG, Bladstrom A, Andersson G (2007) Recurrence in patients with oral and oropharyngeal squamous cell carcinoma: human papillomavirus and other risk factors. Acta Otolaryngol 127:980–987PubMedCrossRef Rosenquist K, Wennerberg J, Annertz K, Schildt EB, Hansson BG, Bladstrom A, Andersson G (2007) Recurrence in patients with oral and oropharyngeal squamous cell carcinoma: human papillomavirus and other risk factors. Acta Otolaryngol 127:980–987PubMedCrossRef
17.
Zurück zum Zitat Hashibe M, Boffetta P, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D, Fabianova E, Rudnai P, Brennan P (2007) Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in Central Europe. Am J Epidemiol 165:814–820PubMedCrossRef Hashibe M, Boffetta P, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D, Fabianova E, Rudnai P, Brennan P (2007) Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in Central Europe. Am J Epidemiol 165:814–820PubMedCrossRef
18.
Zurück zum Zitat Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP, Dal Maso L, Daudt AW, Fabianova E, Fernandez L, Wunsch-Filho V, Franceschi S, Hayes RB, Herrero R, Koifman S, La Vecchia C, Lazarus P, Levi F, Mates D, Matos E, Menezes A, Muscat J, Eluf-Neto J, Olshan AF, Rudnai P, Schwartz SM, Smith E, Sturgis EM, Szeszenia-Dabrowska N, Talamini R, Wei Q, Winn DM, Zaridze D, Zatonski W, Zhang ZF, Berthiller J, Boffetta P (2007) Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 99:777–789PubMedCrossRef Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP, Dal Maso L, Daudt AW, Fabianova E, Fernandez L, Wunsch-Filho V, Franceschi S, Hayes RB, Herrero R, Koifman S, La Vecchia C, Lazarus P, Levi F, Mates D, Matos E, Menezes A, Muscat J, Eluf-Neto J, Olshan AF, Rudnai P, Schwartz SM, Smith E, Sturgis EM, Szeszenia-Dabrowska N, Talamini R, Wei Q, Winn DM, Zaridze D, Zatonski W, Zhang ZF, Berthiller J, Boffetta P (2007) Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 99:777–789PubMedCrossRef
19.
Zurück zum Zitat Hashibe M, Boffetta P, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D, Janout V, Fabianova E, Bencko V, Moullan N, Chabrier A, Hung R, Hall J, Canzian F, Brennan P (2006) Evidence for an important role of alcohol- and aldehyde-metabolizing genes in cancers of the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev 15:696–703PubMedCrossRef Hashibe M, Boffetta P, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D, Janout V, Fabianova E, Bencko V, Moullan N, Chabrier A, Hung R, Hall J, Canzian F, Brennan P (2006) Evidence for an important role of alcohol- and aldehyde-metabolizing genes in cancers of the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev 15:696–703PubMedCrossRef
20.
Zurück zum Zitat Boffetta P, Hashibe M, La Vecchia C, Zatonski W, Rehm J (2006) The burden of cancer attributable to alcohol drinking. Int J Cancer 119:884–887PubMedCrossRef Boffetta P, Hashibe M, La Vecchia C, Zatonski W, Rehm J (2006) The burden of cancer attributable to alcohol drinking. Int J Cancer 119:884–887PubMedCrossRef
21.
22.
Zurück zum Zitat El Naggar A, Reichart PA (2005) Proliferative verrucous leukoplakia and precancerous conditions. IARC Press, Lyon El Naggar A, Reichart PA (2005) Proliferative verrucous leukoplakia and precancerous conditions. IARC Press, Lyon
23.
Zurück zum Zitat Driemel O, Kunkel M, Hullmann M, von Eggeling F, Muller-Richter U, Kosmehl H, Reichert TE (2007) Diagnosis of oral squamous cell carcinoma and its precursor lesions. J Dtsch Dermatol Ges 5:1095–1100PubMedCrossRef Driemel O, Kunkel M, Hullmann M, von Eggeling F, Muller-Richter U, Kosmehl H, Reichert TE (2007) Diagnosis of oral squamous cell carcinoma and its precursor lesions. J Dtsch Dermatol Ges 5:1095–1100PubMedCrossRef
24.
Zurück zum Zitat Reibel J (2003) Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med 14:47–62PubMedCrossRef Reibel J (2003) Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med 14:47–62PubMedCrossRef
25.
Zurück zum Zitat Scanlan MJ, Simpson AJ, Old LJ (2004) The cancer/testis genes: review, standardization, and commentary. Cancer Immun 4:1PubMed Scanlan MJ, Simpson AJ, Old LJ (2004) The cancer/testis genes: review, standardization, and commentary. Cancer Immun 4:1PubMed
26.
Zurück zum Zitat Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT (2002) Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 188:22–32PubMedCrossRef Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT (2002) Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 188:22–32PubMedCrossRef
27.
Zurück zum Zitat Muller-Richter UD, Dowejko A, Zhou W, Reichert TE, Driemel O (2008) Different expression of MAGE-A-antigens in foetal and adult keratinocyte cell lines. Oral Oncol 44:628–633PubMedCrossRef Muller-Richter UD, Dowejko A, Zhou W, Reichert TE, Driemel O (2008) Different expression of MAGE-A-antigens in foetal and adult keratinocyte cell lines. Oral Oncol 44:628–633PubMedCrossRef
28.
Zurück zum Zitat Ries J, Vairaktaris E, Mollaoglu N, Wiltfang J, Neukam FW, Nkenke E (2008) Expression of melanoma-associated antigens in oral squamous cell carcinoma. J Oral Pathol & Med 37:88–93CrossRef Ries J, Vairaktaris E, Mollaoglu N, Wiltfang J, Neukam FW, Nkenke E (2008) Expression of melanoma-associated antigens in oral squamous cell carcinoma. J Oral Pathol & Med 37:88–93CrossRef
29.
Zurück zum Zitat Ries J, Schultze-Mosgau S, Neukam F, Diebel E, Wiltfang J (2005) Investigation of the expression of melanoma antigen-encoding genes (MAGE-A1 to -A6) in oral squamous cell carcinomas to determine potential targets for gene-based cancer immunotherapy. Int J Oncol 26:817–824PubMed Ries J, Schultze-Mosgau S, Neukam F, Diebel E, Wiltfang J (2005) Investigation of the expression of melanoma antigen-encoding genes (MAGE-A1 to -A6) in oral squamous cell carcinomas to determine potential targets for gene-based cancer immunotherapy. Int J Oncol 26:817–824PubMed
30.
Zurück zum Zitat Rimoldi D, Salvi S, Schultz-Thater E, Spagnoli GC, Cerottini JC (2000) Anti-MAGE-3 antibody 57B and anti-MAGE-1 antibody 6C1 can be used to study different proteins of the MAGE-A family. Int J Cancer 86:749–751PubMedCrossRef Rimoldi D, Salvi S, Schultz-Thater E, Spagnoli GC, Cerottini JC (2000) Anti-MAGE-3 antibody 57B and anti-MAGE-1 antibody 6C1 can be used to study different proteins of the MAGE-A family. Int J Cancer 86:749–751PubMedCrossRef
31.
Zurück zum Zitat Lee KD, Eura M, Ogi K, Nakano K, Chikamatsu K, Masuyama K, Ishikawa T (1996) Expression of the MAGE-1, -2, -3, -4, and -6 genes in non-squamous cell carcinoma lesions of the head and neck. Acta Otolaryngol 116:633–639PubMedCrossRef Lee KD, Eura M, Ogi K, Nakano K, Chikamatsu K, Masuyama K, Ishikawa T (1996) Expression of the MAGE-1, -2, -3, -4, and -6 genes in non-squamous cell carcinoma lesions of the head and neck. Acta Otolaryngol 116:633–639PubMedCrossRef
32.
Zurück zum Zitat Hudolin T, Juretic A, Spagnoli GC, Pasini J, Bandic D, Heberer M, Kosicek M, Cacic M (2006) Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue. Prostate 66:13–18PubMedCrossRef Hudolin T, Juretic A, Spagnoli GC, Pasini J, Bandic D, Heberer M, Kosicek M, Cacic M (2006) Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue. Prostate 66:13–18PubMedCrossRef
33.
Zurück zum Zitat Tamura G (2006) Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol 12:192–198PubMed Tamura G (2006) Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol 12:192–198PubMed
34.
Zurück zum Zitat Müller-Richter UD, Dowejko A, Peters S, Rauthe S, Reuther T, Gattenlöhner S, Reichert TE, Driemel O, Kübler AC (2009) MAGE-A antigens in patients with primary oral squamous cell carcinoma. Clin Oral Investig. 2 June 2009 [Epub ahead of print] Müller-Richter UD, Dowejko A, Peters S, Rauthe S, Reuther T, Gattenlöhner S, Reichert TE, Driemel O, Kübler AC (2009) MAGE-A antigens in patients with primary oral squamous cell carcinoma. Clin Oral Investig. 2 June 2009 [Epub ahead of print]
35.
Zurück zum Zitat Müller-Richter UDA, Dowejko A, Reuther T, Kleinheinz J, Reichert TE, Driemel O (2008) Analysis of expression profiles of MAGE-A antigens in oral squamous cell carcinoma cell lines. Head Face Med 5:10CrossRef Müller-Richter UDA, Dowejko A, Reuther T, Kleinheinz J, Reichert TE, Driemel O (2008) Analysis of expression profiles of MAGE-A antigens in oral squamous cell carcinoma cell lines. Head Face Med 5:10CrossRef
36.
Zurück zum Zitat Driemel O, Dahse R, Berndt A, Pistner H, Hakim SG, Zardi L, Reichert TE, Kosmehl H (2007) High-molecular tenascin-C as an indicator of atypical cells in oral brush biopsies. Clin Oral Investig 11:93–99PubMedCrossRef Driemel O, Dahse R, Berndt A, Pistner H, Hakim SG, Zardi L, Reichert TE, Kosmehl H (2007) High-molecular tenascin-C as an indicator of atypical cells in oral brush biopsies. Clin Oral Investig 11:93–99PubMedCrossRef
Metadaten
Titel
MAGE-A antigens in lesions of the oral mucosa
verfasst von
Eva Krauss
Stephan Rauthe
Stefan Gattenlöhner
Tobias Reuther
Michael Kochel
Ulrike Kriegebaum
Alexander C. Kübler
Urs D. A. Müller-Richter
Publikationsdatum
01.06.2011
Verlag
Springer-Verlag
Erschienen in
Clinical Oral Investigations / Ausgabe 3/2011
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-010-0387-9

Weitere Artikel der Ausgabe 3/2011

Clinical Oral Investigations 3/2011 Zur Ausgabe

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.